Navigation Links
Halozyme to Present New Data on PEGPH20 in Pancreatic Cancer at European Cancer Congress
Date:9/12/2013

ncerning the possible activity, benefits and attributes of PEGPH20, the possible method of action of PEGPH20, future clinical trials for PEGPH20, the development of the HA diagnostic tool and the potential uses of such tool and the possible utility of PEGPH20 in pancreatic cancer and other tumors. The forward-looking statements are usually (but not always) identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of risks and uncertainties including clinical trial enrollment and results, regulatory approval requirements, unexpected expenditures and costs, unexpected results or delays in development and regulatory review, unexpected adverse events and competitive conditions. These and other factors that may result in differences are discussed in greater detail in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 7, 2013. Halozyme does not undertake to update these forward-looking statements.

References
1. American Cancer Society, Cancer Facts & Figures 2013Atlanta: American Cancer Society; 2013.
2. Pancreatic Cancer, American Cancer Society, http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics  Accessed April 18, 2013.

Investor Contact:
David Ramsay
Halozyme Therapeutics
858-704-8260
ir
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in European Union
2. Halozyme Reports Second Quarter 2013 Financial Results
3. Halozyme Provides Update on ViroPharma Phase 2 Trial of Subcutaneous Cinryze (C1 Esterase Inhibitor [Human]) Formulation with rHuPH20
4. Halozyme to Host Second Quarter 2013 Financial Results Conference Call
5. Halozymes Phase 1b Clinical Trial Of PEGPH20 With Gemcitabine Indicates Positive Activity Against Pancreatic Cancer
6. Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer
7. Halozyme Reports First Quarter 2013 Financial Results
8. Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
9. Halozyme Therapeutics Names Matt Posard to Board of Directors
10. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... and DUBLIN , ... TNIB) ("we" or the "Company"), a biotechnology company ... for autoimmune diseases in emerging nations, today announced ... our common stock for DTC,s Deposit and Withdrawal ... Securities Transfer Service ("FAST") transfer agent as the ...
(Date:9/23/2014)... 23, 2014 Research and Markets  has announced ... report to their offering. Diabetes is ... globe. Over 382 million people are estimated to be currently ... to 592 million by 2035. With a very high ... and India , an increasing ...
(Date:9/23/2014)... -- The Pennsylvania State Police will accept unwanted, expired and ... National Prescription Drug Take-Back Day. The service is free ... is a national initiative, conducted in partnership with the ... public to dispose of expired, unused or unwanted prescription ... From 10 a.m. to 2 p.m., unwanted prescription ...
Breaking Medicine Technology:TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Techne Corporation,s (NASDAQ: TECH ) financial results for ... First quarter earnings were $27.5 million or $.74 ... to $30.0 million or $.81 per diluted share after adjustment ... of inventory that was written-up to fair value as part ...
... PAREXEL International Corporation (NASDAQ: PRXL ... today announced that the Company has expanded ... dedicated support for their commercialization goals ... services to help clients maximize regional and global ...
Cached Medicine Technology:Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 2Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 3Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 4Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 5Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 6Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 7Techne Corporation Releases Unaudited First Quarter Fiscal Year 2012 Financial Results 8PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 2PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 3PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 4PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value 5
(Date:9/23/2014)... developing, bringing with its advances promises of individualized ... treatment interventions. Genetic tests are already guiding ... hepatitis c virus (HPC), and emerging research is ... for an individual,s susceptibility to addiction to a ... While there appear to be many benefits inherent ...
(Date:9/23/2014)... 2014 Grinnell Mutual seeks submissions ... in the Midwest. Working Together Making It Better ... organizations with projects positively impacting their communities. , ... make their communities a better places,” said ... Relations Barb Baker. “Their leadership—as coaches, as volunteers, ...
(Date:9/23/2014)... News) -- The number of ,rogue, wholesale distributors ... so doctors need to be vigilant when purchasing ... Tuesday. In a statement, the agency said ... launched a program to educate doctors and other ... purchasing procedures. The program aims to protect patients ...
(Date:9/23/2014)... showing the benefits of preventing a reduction in ... was released today by the American College of ... Save the Medicaid Primary Care Pay Parity Program: ... Life-Saving Primary Care Will Expire," explains why it ... internists and pediatricians (and their related subspecialists), family ...
(Date:9/23/2014)... Viejo, California (PRWEB) September 23, 2014 ... the Oracle services market. Included are Oracle ... Resource Augmentation. Trevera supports all versions of Oracle ... associated point releases. , Trevera has announced ... for organizations that need help with their software ...
Breaking Medicine News(10 mins):Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3
... RIDGE, N.J., Feb. 20 When Avaya ... exhibition show floor of HIMSS08,next week, onboard ... Communications,solutions that are helping healthcare organizations address ... Avaya Inc.,is a leading global provider of ...
... HATBORO, Pa., Feb. 20 InfoLogix, Inc.,(Nasdaq: ... mobility,solutions for the healthcare and commercial industries, announced ... at the Growth & Value,Investor Conference to be ... on,February 27-28, 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... Existing ... Vendor ... of,point-of-care charge capture technologies, today announced that Kentucky,Medical Services Foundation ... clinician base of more than 600 providers., MedAptus, Professional ...
... Cyberonics, Inc. (Nasdaq:,CYBX) today announced results for the ... Financial highlights, Net sales, Net sales ... million,compared to $28.9 million in the second quarter of ... fiscal 2007. Net sales for the nine months,ended January ...
... Evidence Base for MEDIHONEY(TM) Dressings Growing, PRINCETON, ... Board: DSCI), a provider of advanced wound care ... usage of its,newly released MEDIHONEY(TM) Wound & Burn ... at the upcoming annual,American Professional Wound Care Association ...
... Las Vegas Training Facility, FREMONT, Calif., Feb. ... and aesthetic lasers, today announced an agreement with,The ... an,internationally recognized leader in post-graduate dental education, in,which ... utilized at,LVI,s state-of-the-art teaching facility through 2009. The ...
Cached Medicine News:Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 2Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 3Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 4Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 2Health News:InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL 3Health News:MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 2Health News:MedAptus Selected by Kentucky Medical Services Foundation for Professional Charge Capture Technology 3Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 2Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 3Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 4Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 5Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 6Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 7Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 8Health News:Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program 9Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 2Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 3Health News:Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference 4Health News:HOYA ConBio Announces Educational Agreement With LVI Global 2
... Verisyse Phakic IOL is used to ... medical term for nearsightedness. With over ... procedures performed worldwide, results prove that ... effective for very nearsighted people who ...
... CELL-DYN 3200 sets a benchmark of ... scatter for WBC, RBC, PLT and ... the needs of today's laboratory. The ... differential analysis, automated sample handling, comprehensive ...
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
Inquire...
Medicine Products: